DCTH · Delcath Systems, Inc. · Webcasts, Transcripts & Audio
$15.41
-0.46 (-2.90%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$553.10M
Shares
34.70M
Volume · Oct 6
244.83K
Avg daily vol (3M)
481.56K
Delcath Systems, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Delcath Systems, Inc. (DCTH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$797,000
−$10.16M
'22 Q2
22-06-30
·
$906,000
−$8.88M
'22 Q3
22-09-30
·
$638,000
−$8.47M
'22 Q4
23-03-27
▲57.9%
$597,000
−$9.00M
'23 Q1
23-05-12
▼52.1%
$434,000
−$20.34M
'23 Q3
23-11-13
▼15.5%
$539,000
−$11.14M
'23 Q4
24-03-26
▲425.8%
$3.14M
−$11.11M
'24 Q1
24-05-14
▲1468.9%
$7.77M
−$13.74M
'24 Q2
24-08-05
▲2480.6%
$11.20M
$1.86M
'24 Q3
24-11-08
▲2701.5%
$15.10M
−$3.40M
'24 Q4
25-03-06
▲530.3%
$19.78M
$1.07M
'25 Q1
25-05-08
▲211%
$24.16M
$2.70M
'25 Q2
25-08-06
▲83.6%
$20.56M
$830,000
'25 Q3
25-10-20
▲37.3%
$20.73M
−$1.90M
'25 Q4
26-02-26
▲26.3%
$24.99M
−$1.07M
'26 Q1
26-05-07
LATEST
▲20.6%
$29.13M
$2.67M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call Transcript
Confident tone
Clinical pipeline in liver-dominant cancers
R&D investment
Treatment center activation and expansion
Revenue
$29.13M
▲ 20.6% YoY Diluted EPS
$0.07
▲ 0% YoY Gross margin
89.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Delcath Systems, Inc. (DCTH) Q1 2026 Earnings Call Transcript
Positive tone
Metastatic colorectal cancer (CRC) Phase II trial
Center activations and commercial expansion
Hepzato/Kit revenue and volume growth
Revenue
$24.99M
▲ 26.3% YoY Diluted EPS
$-0.03
▼ 200% YoY Gross margin
85.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Delcath Systems, Inc. (DCTH) Q4 2025 Earnings Call Transcript
Confident tone
Seasonality and capacity variability
Referral network development
CHOPIN trial data and clinical evidence
Revenue
$20.73M*
▲ 37.3% YoY Gross margin
85.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-20
Delcath Systems, Inc. (DCTH) Q3 2025 Earnings Call Transcript
Positive tone
CHOPIN trial results
Financial outlook and capital
Pipeline expansion (CRC, breast, NSCLC)
Revenue
$20.56M
▲ 83.6% YoY Diluted EPS
$0.02
▼ 66.7% YoY Gross margin
87.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Delcath Systems, Inc. (DCTH) Q2 2025 Earnings Call Transcript
Positive tone
340B / National Drug Rebate Agreement (NDRA) pricing
HEPZATO commercial launch and revenue growth
CHEMOSAT European sales and clinical-site leverage
Revenue
$24.16M
▲ 211% YoY Diluted EPS
$0.07
Gross margin
86.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call Transcript
Confident tone
Revenue growth
Pipeline trials
European market
Revenue
$19.78M
▲ 530.3% YoY Diluted EPS
$0.03
Gross margin
85.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-06
Delcath Systems, Inc. (DCTH) Q4 2024 Earnings Call Transcript
Confident tone
HEPZATO U.S. launch and revenue ramp
Clinical trials and pipeline expansion
European CHEMOSAT growth
Revenue
$15.10M*
▲ 2701.5% YoY Gross margin
85.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Delcath Systems, Inc. (DCTH) Q3 2024 Earnings Call Transcript
Confident tone
Pipeline Expansion Beyond Uveal Melanoma
CHEMOSAT European Sales
CHOPIN and SCANDIUM 3 Trials
Revenue
$11.20M
▲ 2480.6% YoY Diluted EPS
$0.06
Gross margin
85.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Delcath Systems, Inc. (DCTH) Q2 2024 Earnings Call Transcript
Positive tone
CHEMOSAT European sales
HEPZATO U.S. revenue
Center activation and site ramp
Revenue
$7.77M
▲ 1468.9% YoY Diluted EPS
$-0.48
Gross margin
80.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Delcath Systems, Inc. (DCTH) Q1 2024 Earnings Call Transcript
Confident tone
U.S. Commercial Launch / Center Activation
Reimbursement / J-Code
Oncology Referrals and Market Penetration
Revenue
$3.14M
▲ 425.8% YoY Diluted EPS
$-0.45
Gross margin
71.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-26
Delcath Systems, Inc. (DCTH) Q4 2023 Earnings Call Transcript
Confident tone
Reimbursement and coding
Commercial launch of HEPZATO KIT
Liver-directed therapy evidence and pipeline
Revenue
$539,000*
▼ 15.5% YoY Gross margin
68.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Delcath Systems, Inc. (DCTH) Q3 2023 Earnings Call Transcript
Revenue
$434,000
▼ 52.1% YoY Diluted EPS
$-1.14
Gross margin
69.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-12
Delcath Systems, Inc. (DCTH) Q1 2023 Earnings Call Transcript
Revenue
$597,000
▲ 57.9% YoY Diluted EPS
$-0.77
Gross margin
69.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-27
Delcath Systems, Inc. (DCTH) Q4 2022 Earnings Call Transcript
Revenue
$638,000*
Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Delcath Systems, Inc. (DCTH) Q3 2022 Earnings Call Transcript
Revenue
$906,000
Diluted EPS
$-0.96
Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Delcath Systems, Inc. (DCTH) Q2 2022 Earnings Call Transcript
Revenue
$797,000
Diluted EPS
$-1.24
Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Delcath Systems, Inc. (DCTH) Q1 2022 Earnings Call Transcript
Revenue
$378,000
Diluted EPS
$-1.10
Gross margin
91.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Delcath Systems, Inc. (DCTH) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Delcath Systems, Inc. (DCTH) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Delcath Systems, Inc. (DCTH) Q2 2021 Earnings Call Transcript
Diluted EPS
$-0.96
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
Delcath Systems, Inc. (DCTH) Q1 2021 Earnings Call Transcript
Diluted EPS
$-1.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Delcath Systems, Inc. (DCTH) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Delcath Systems, Inc. (DCTH) Q3 2020 Earnings Call Transcript
Diluted EPS
$-1.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-18
Delcath Systems, Inc. (DCTH) Q2 2020 Earnings Call Transcript
Diluted EPS
$-1.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 webcasts